Wendy Teft International Celiac Disease Symposium 2026

Wendy Teft

Wendy Teft is Vice President at AcelaBio, Inc., where she leads business and commercial operations for the company's histopathology and precision medicine services. She previously served as Vice President, Precision Medicine at Alimentiv, Inc., a specialized gastroenterology CRO, leading the operational delivery of clinical pharmacology and translational medicine studies for pharmaceutical, biotech, and academic clients. Dr. Teft holds a PhD in Immunology from Western University and has over 15 years of experience working with clinicians, scientists, and pharmaceutical organizations across multiple functions to implement the use of individually tailored therapies in the clinic and to support the identification of biomarkers during clinical drug development. Dr. Teft brings deep expertise in histopathology and precision medicine, having launched her career in Personalized Medicine, focusing on optimizing individual treatment strategies for oncology and inflammatory bowel disease patients at London Health Sciences Centre, London, Ontario, Canada.

Abstracts this author is presenting: